Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lymphoma 5 Lung Neoplasms 5 Multiple Myeloma 4 Lymphoma, Large-Cell, Anaplastic 4 Neuroblastoma 3 Neoplasms 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Neurofibromatosis 2 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

Fluorouracil 34 Cisplatin 34 Radiotherapy 30 Oxaliplatin 30 Paclitaxel 22 pembrolizumab 20 Irinotecan 20 Docetaxel 20 Leucovorin 19 Capecitabine 16 Cetuximab 11 Carboplatin 11 Bevacizumab 11 Surgical Procedures, Operative 9 Radiation 9 Trastuzumab 8 Panitumumab 6 Epirubicin 6 Neoadjuvant Therapy 5 Esophagectomy 4 Erlotinib Hydrochloride 4 Chemotherapy, Adjuvant 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Microarray Analysis 3 Immunohistochemistry 3 Gene Expression Profiling 3 Gemcitabine 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡